agilon health Receives Notice Of Non-Compliance From NYSE; Co Intends To Seek Shareholder Approval For Reverse Stock Split

To regain compliance agilon intends to seek shareholder approval for a reverse stock split

agilon health, inc. (the "Company") (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that the New York Stock Exchange (the "NYSE") issued a notice (the "Notice") on November 5, 2025 informing the Company that it is no longer in compliance with its continued listing standards because the average closing price of the Company's common stock was less than $1.00 per share over a consecutive 30 trading-day period ended November 4, 2025 (the "Price Criteria for Capital or Common Stock").

The Notice has no immediate impact on the listing of the Company's common stock, which will continue to be listed and traded on the NYSE during a cure period, subject to the Company's compliance with other NYSE continued listing standards. Furthermore, the Notice is not anticipated to impact the ongoing business operations of the Company or its reporting requirements with the U.S. Securities and Exchange Commission.

The Company plans to notify the NYSE by November 19, 2025 that it intends to remain listed on the NYSE. To regain compliance with the Price Criteria for Capital or Common Stock, the Company anticipates pursuing a reverse stock split, subject to approval by the Company's stockholders. The Company expects to seek stockholder approval at its annual general meeting in 2026.